Home > Insider Trading > Adhera Therapeutics Inc. > Profile

Adhera Therapeutics Inc. (ATRX)

Market is closed

Sector: Pharmaceutical Preparations

Related Insiders

Jr L Charles Rice, Director, 2022-04-28
Kydd Trond Waerness, Director, 2022-04-21
Zahed Subhan, Director, 2021-11-29

Jr L Charles Rice, Director, 2022-04-28
Kydd Trond Waerness, Director, 2022-04-21
Zahed Subhan, Director, 2021-11-29
Albert Andrew Kucharchuk, Chief Executive Officer, 2020-07-20
L. Rhonda Stanley, Svp Finance & Accounting, 2019-11-05
R. Nancy Phelan, Ceo And Secretary, 2019-04-04
Eric Robert Teague, Chief Financial Officer, 2019-01-17
Vuong Trieu, Large Shareholder, Director, 2018-10-04
Jr. Robert Moscato, Chief Executive Officer, 2018-07-17
Erik Emerson, Chief Commercial Officer, 2018-07-12
Uli Hacksell, Director, 2018-07-11
Timothy Boris, Director, 2018-05-07
W. Joseph Ramelli, Other, 2018-05-04
Philippe Calais, Other, 2018-05-04
C Philip Ranker, Other, 2018-05-04
Larn Hwang, Chief Scientific Officer, 2018-04-19
Allen Donald Williams, Director, 2018-04-19
Isaac Blech, Director, 2018-04-19
D. Peter Weinstein, Chief Legal Officer, 2017-10-24
B. Amit Shah, Chief Financial Officer, 2017-10-06
Mihir Munsif, Chief Operating Officer, 2017-02-14
Stefan Loren, Director, 2017-01-04
Autotelic Llc, Large Shareholder, 2016-11-25
Michael J French, President And Ceo, 2015-01-02
E. Daniel Geffken, Interim Cfo, 2014-06-02
Llp Cashman Pryor, Large Shareholder, 2014-02-11
Theodore Richard Ho, Executive Vice President - R&D, 2014-01-06
Biomed Realty Trust Inc, Large Shareholder, 2011-10-04
Peter Parker, Director, 2011-09-07
Douglas Michael Taylor, Director, 2011-09-07
Gregory Sessler, Director, 2011-09-07
John R Fletcher, Director, 2011-09-07
James Karis, Director, 2011-09-07
Barry Polisky, Chief Scientific Officer, 2011-08-29
S Peter Garcia, Chief Financial Officer, 2011-08-29
Ltd Bioventures Novartis, Large Shareholder, 2011-01-27
Ag Novartis, Large Shareholder, 2011-01-27
J Chiang Li, Director, 2010-07-23
C Steven Quay, Director, 2009-03-20

Show All Insiders (39)

Hedge Fund Popularity

Display

Display Share Price

Display Standard Version

Hedge Fund Holdings

Filing Period:

Last updated on August 17, 2017, 5:32 pm based on SEC 13F filings Last update: August 17, 2017, 5:32 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Pine River Capital Management Brian Taylor	0	$0	-100%	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Trieu	$0.39	10,000	Large Shareholder, Officer, Director	11,127,141	2017-06-09	Filing
Trieu	$0.38	2,500	Large Shareholder, Officer, Director	11,097,141	2017-06-07	Filing
Trieu	$0.39	20,000	Large Shareholder, Officer, Director	11,117,141	2017-06-08	Filing
Ramelli	$0.34	13,000	Officer	418,153	2017-04-06	Filing
Ramelli	$0.43	22,500	Officer	440,653	2017-04-07	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Pryor	$1.02	15,000	Large Shareholder	1,591,959	2014-02-10	Filing
Pryor	$1.01	59,000	Large Shareholder	1,606,959	2014-02-07	Filing
Pryor	$0.95	34,041	Large Shareholder	1,665,959	2014-02-06	Filing
Pryor	$0.24	35,000	Large Shareholder	1,700,000	2013-10-04	Filing
Pryor	$0.25	65,000	Large Shareholder	1,735,000	2013-10-03	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Byrne Asset Management Llc	421	$42,407	0.03%
2.	Huntington National Bank	1	$0	0%